DARK MATTER THERAPEUTICS, INC.

Biotech · Private

AI-driven discovery platform for multi-target small molecule therapeutics targeting opioid use disorder

Grants
$399K
1 award
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase I · AI-Powered chemical-pathway-patient-directed polypharmacology for OUD therapy$399,414
Federal grant · SBIR/STTR

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1095ROUND TABLE RESEARCH, INC.——
1096NANO-BEADS PROTEIN INNOVATIONS, INC.——
1097VORTEX THERAPEUTICS INC——
1098DARK MATTER THERAPEUTICS, INC.——
1099UFORCE BIOTECHNOLOGY, LLC——
1100PICCOLO BIOSYSTEMS, INC.——
1101GENTIBIO, INC.——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.